Literature DB >> 185683

Inhibition of elastase from granulocytes by the low molecular weight bronchial protease inhibitor.

K Ohlsson, H Tegner.   

Abstract

The low molecular weight bronchial protease inhibitor isolated from purulent bronchial secretions of man was shown to be a potent inhibitor of the elastase from human granulocytes. At a molar ratio of 1:1, the inhibitor prevented elastase digestion of insoluble elastin and soluble elastin, and blocked the hydrolysis of t-BOC-L-alanine-p-nitrophenyl ester. The collagenolytic activity of granulocyte collagenase was not inhibited by the bronchial inhibitor. Antisera were raised in rabbits for the isolation of specific IgG fractions in order to localize and quantitate the inhibitor. 125I-labelled inhibitor was used to study enzyme interactions further by gel filtration. These studies demonstrated that the bronchial inhibitor formed firm complexes with granulocyte elastase but did not form complexes with granulocyte collagenase.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 185683     DOI: 10.3109/00365517609054461

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  18 in total

Review 1.  Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor.

Authors:  Stergios Doumas; Alexandros Kolokotronis; Panagiotis Stefanopoulos
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

2.  Chemotactic factor inactivators of human granulocytes.

Authors:  J P Brozna; R M Senior; D L Kreutzer; P A Ward
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

3.  Receptor-mediated binding and internalization of leukocyte elastase by alveolar macrophages in vitro.

Authors:  E J Campbell; R R White; R M Senior; R J Rodriguez; C Kuhn
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

Review 4.  Low-molecular-weight protease inhibitor of the respiratory tract.

Authors:  J A Kramps; C Franken
Journal:  Surv Immunol Res       Date:  1982

5.  Localisation of a low-molecular-weight bronchial protease inhibitor in the peripheral human lung.

Authors:  H W Mooren; J A Kramps; C Franken; C J Meijer; J A Dijkman
Journal:  Thorax       Date:  1983-03       Impact factor: 9.139

6.  Biochemical definition of human tracheobronchial mucus.

Authors:  P Roussel; P Degand; G Lamblin; A Laine; J J Lafitte
Journal:  Lung       Date:  1978       Impact factor: 2.584

7.  Detection of extracellular neutrophil elastase in hamster lungs after intratracheal instillation of E. coli lipopolysaccharide using a fluorogenic, elastase-specific, synthetic substrate.

Authors:  A Rudolphus; J Stolk; C van Twisk; C J van Noorden; J H Dijkman; J A Kramps
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

8.  Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.

Authors:  J E Gadek; G A Fells; R L Zimmerman; S I Rennard; R G Crystal
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

9.  Inhibition of human pancreatic proteinases by mucus proteinase inhibitor, eglin c and aprotinin.

Authors:  D Belorgey; S Dirrig; M Amouric; C Figarella; J G Bieth
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

10.  Influence of elastin on the inhibition of leucocyte elastase by alpha 1-proteinase inhibitor and bronchial inhibitor. Potent inhibition of elastin-bound elastase by bronchial inhibitor.

Authors:  M Bruch; J G Bieth
Journal:  Biochem J       Date:  1986-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.